Research programme: BNP aerosol - mondoBIOTECHAlternative Names: Aerosolised brain natriuretic peptide - mondoBIOTECH; B-type natriuretic peptide - mondoBIOTECH; BNP
Latest Information Update: 16 Jul 2016
At a glance
- Originator mondoBIOTECH
- Class Heart failure therapies; Natriuretic peptides; Nerve tissue proteins
- Mechanism of Action Diuretics
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Lung disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Lung-disorders in Germany (Inhalation, Aerosol)
- 17 Sep 2009 Preclinical development for Lung disorders in Germany (Inhalation)